Published in Gastric Cancer on April 02, 2011
A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer susceptibility. PLoS One (2012) 0.80
Clausenidin induces caspase-dependent apoptosis in colon cancer. BMC Complement Altern Med (2016) 0.75
Caspase-9: structure, mechanisms and clinical application. Oncotarget (2017) 0.75
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer. BMC Cancer (2016) 0.75
CASP8 -652 6N insertion/deletion polymorphism and overall cancer risk: evidence from 49 studies. Oncotarget (2017) 0.75
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Caspases: killer proteases. Trends Biochem Sci (1997) 7.07
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet (2007) 2.98
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene (2002) 2.03
Apoptosome dysfunction in human cancer. Apoptosis (2004) 1.70
Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci (2010) 1.54
CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res (2005) 1.20
A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet (2008) 1.18
Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet (2006) 1.17
Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. Hum Mol Genet (2004) 1.10
CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer (2008) 1.06
Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer (2008) 1.05
Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res (2007) 1.04
Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol (2009) 0.93
Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas (2010) 0.88
Caspase-9 cleavage, do you need it? Biochem J (2007) 0.83
Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS (2006) 0.80
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol (2010) 5.65
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53
Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08
Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax (2007) 1.98
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol (2005) 1.91
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol (2009) 1.67
Allergic rhinitis, asthma, and atopy among grape farmers in a rural population in Crete, Greece. Chest (2005) 1.56
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44
Vascular-specific growth factor mRNA levels in the human diaphragm. Respiration (2005) 1.42
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma (2002) 1.31
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26
TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovasc Intervent Radiol (2012) 1.21
Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol (2010) 1.17
Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15
Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12
Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10
Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature. Anticancer Res (2005) 1.06
Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05
Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses. Int J Oncol (2009) 1.05
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer (2013) 1.04
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study. Cancer Invest (2005) 1.00
E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00
Distant solitary skeletal muscle metastasis from papillary thyroid carcinoma. Int Surg (2007) 0.99
Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J Cell Physiol (2005) 0.95
Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis (2010) 0.95
Muc4/MUC4 functions and regulation in cancer. Future Oncol (2009) 0.95
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study. Oncology (2006) 0.95
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94
Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol (2010) 0.94
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93
Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog (2011) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Transanal polypectomy using single incision laparoscopic instruments. World J Gastrointest Surg (2011) 0.92
Association of allergic rhinitis with pesticide use among grape farmers in Crete, Greece. Occup Environ Med (2006) 0.92
Morbid obesity and sleeve gastrectomy: how does it work? Obes Surg (2010) 0.92
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression. Clin Breast Cancer (2012) 0.91
Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol (2012) 0.91
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group. J Thorac Oncol (2007) 0.91
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Crit Rev Oncol Hematol (2008) 0.90
Direct detection of unamplified DNA from pathogenic mycobacteria using DNA-derivatized gold nanoparticles. J Microbiol Methods (2009) 0.90
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90